Literature DB >> 23543794

TDP-43 frontotemporal lobar degeneration and autoimmune disease.

Zachary A Miller1, Katherine P Rankin, Neill R Graff-Radford, Leonel T Takada, Virginia E Sturm, Clare M Cleveland, Lindsey A Criswell, Philipp A Jaeger, Trisha Stan, Kristin A Heggeli, Sandy Chan Hsu, Anna Karydas, Baber K Khan, Lea T Grinberg, Maria Luisa Gorno-Tempini, Adam L Boxer, Howard J Rosen, Joel H Kramer, Giovanni Coppola, Daniel H Geschwind, Rosa Rademakers, William W Seeley, Tony Wyss-Coray, Bruce L Miller.   

Abstract

BACKGROUND: The aetiology and pathogenesis of non-genetic forms of frontotemporal dementia (FTD) is unknown and even with the genetic forms of FTD, pathogenesis remains elusive. Given the association between systemic inflammation and other neurodegenerative processes, links between autoimmunity and FTD need to be explored.
OBJECTIVE: To describe the prevalence of systemic autoimmune disease in semantic variant primary progressive aphasia (svPPA), a clinical cohort, and in progranulin (PGRN) mutation carriers compared with neurologically healthy normal controls (NC) and Alzheimer's disease (AD) as dementia controls.
DESIGN: Case control.
SETTING: Academic medical centres. PARTICIPANTS: 129 svPPA, 39 PGRN, 186 NC and 158 AD patients underwent chart review for autoimmune conditions. A large subset of svPPA, PGRN and NC cohorts underwent serum analysis for tumour necrosis factor α (TNF-α) levels. OUTCOME MEASURES: χ(2) Comparison of autoimmune prevalence and follow-up logistic regression.
RESULTS: There was a significantly increased risk of autoimmune disorders clustered around inflammatory arthritides, cutaneous disorders and gastrointestinal conditions in the svPPA and PGRN cohorts. Elevated TNF-α levels were observed in svPPA and PGRN compared with NC.
CONCLUSIONS: svPPA and PGRN are associated with increased prevalence of specific and related autoimmune diseases compared with NC and AD. These findings suggest a unique pattern of systemic inflammation in svPPA and PGRN and open new research avenues for understanding and treating disorders associated with underlying transactive response DNA-binding protein 43 aggregation.

Entities:  

Keywords:  DEMENTIA; EPIDEMIOLOGY; IMMUNOLOGY; RHEUMATOLOGY

Mesh:

Substances:

Year:  2013        PMID: 23543794      PMCID: PMC3840954          DOI: 10.1136/jnnp-2012-304644

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  40 in total

1.  Medical and environmental risk factors for sporadic frontotemporal dementia: a retrospective case-control study.

Authors:  S M Rosso; E-J Landweer; M Houterman; L Donker Kaat; C M van Duijn; J C van Swieten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 2.  The role of T cells in cutaneous autoimmune disease.

Authors:  Selwyn Chow; Carina Rizzo; Larisa Ravitskiy; Animesh A Sinha
Journal:  Autoimmunity       Date:  2005-06       Impact factor: 2.815

3.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

4.  Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota.

Authors:  S R Pillemer; E L Matteson; L T Jacobsson; P B Martens; L J Melton; W M O'Fallon; P C Fox
Journal:  Mayo Clin Proc       Date:  2001-06       Impact factor: 7.616

5.  High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome.

Authors:  K D Fine; K Do; K Schulte; F Ogunji; R Guerra; L Osowski; J McCormack
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

6.  Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases.

Authors:  S L Musone; K E Taylor; J Nititham; C Chu; A Poon; W Liao; E T Lam; A Ma; P-Y Kwok; L A Criswell
Journal:  Genes Immun       Date:  2011-02-17       Impact factor: 2.676

7.  Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications.

Authors:  M Sjögren; S Folkesson; K Blennow; E Tarkowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 8.  Sarcoidosis and the rheumatologist.

Authors:  Karina D Torralba; Francisco P Quismorio
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

9.  Steroid treatment of primary progressive aphasia.

Authors:  David A Decker; Kenneth M Heilman
Journal:  Arch Neurol       Date:  2008-11

10.  Emerging patterns of genetic overlap across autoimmune disorders.

Authors:  Corinne Richard-Miceli; Lindsey A Criswell
Journal:  Genome Med       Date:  2012-01-27       Impact factor: 11.117

View more
  66 in total

Review 1.  Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.

Authors:  Deepti Lall; Robert H Baloh
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

2.  Neurodegenerative disease: Frontotemporal dementia--time to target inflammation?

Authors:  Olivier Piguet
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

Review 3.  Therapy and clinical trials in frontotemporal dementia: past, present, and future.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

4.  C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.

Authors:  Micaela Fredi; Ilaria Cavazzana; Giorgio Biasiotto; Massimiliano Filosto; Alessandro Padovani; Eugenio Monti; Angela Tincani; Franco Franceschini; Isabella Zanella
Journal:  Neuromolecular Med       Date:  2019-03-11       Impact factor: 3.843

5.  Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.

Authors:  Ione O C Woollacott; Jennifer M Nicholas; Carolin Heller; Martha S Foiani; Katrina M Moore; Lucy L Russell; Ross W Paterson; Ashvini Keshavan; Jonathan M Schott; Jason D Warren; Amanda Heslegrave; Henrik Zetterberg; Jonathan D Rohrer
Journal:  Dement Geriatr Cogn Disord       Date:  2020-04-28       Impact factor: 2.959

6.  Fluid Biomarkers of Frontotemporal Lobar Degeneration.

Authors:  Emma L van der Ende; John C van Swieten
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Microglial NFκB-TNFα hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia.

Authors:  Grietje Krabbe; S Sakura Minami; Jon I Etchegaray; Praveen Taneja; Biljana Djukic; Dimitrios Davalos; David Le; Iris Lo; Lihong Zhan; Meredith C Reichert; Faten Sayed; Mario Merlini; Michael E Ward; David C Perry; Suzee E Lee; Ana Sias; Christopher N Parkhurst; Wen-Biao Gan; Katerina Akassoglou; Bruce L Miller; Robert V Farese; Li Gan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 8.  RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Authors:  Jeffrey W Hofmann; William W Seeley; Eric J Huang
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

Review 9.  Frontotemporal dementia.

Authors:  Jee Bang; Salvatore Spina; Bruce L Miller
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

Review 10.  Primary progressive aphasia and the evolving neurology of the language network.

Authors:  M-Marsel Mesulam; Emily J Rogalski; Christina Wieneke; Robert S Hurley; Changiz Geula; Eileen H Bigio; Cynthia K Thompson; Sandra Weintraub
Journal:  Nat Rev Neurol       Date:  2014-09-02       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.